Analyst Recommendations
0.95 0.06(6.48%)10/04/2024
Adaptimmune Therapeutics Plc (ADAP)
Adaptimmune Therapeutics Plc (ADAP)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 3 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades